Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM
· Real-Time Price · USD
8.42
-0.76 (-8.28%)
At close: May 07, 2025, 3:59 PM
8.09
-3.92%
After-hours: May 07, 2025, 07:23 PM EDT
-8.28% (1D)
| Bid | 8.27 |
| Market Cap | 19.36M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -13.12 |
| PE Ratio (ttm) | -0.64 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 8.78 |
| Volume | 120,436 |
| Avg. Volume (20D) | 638,851 |
| Open | 9.05 |
| Previous Close | 9.18 |
| Day's Range | 8.33 - 9.24 |
| 52-Week Range | 2.70 - 25.35 |
| Beta | 0.91 |
About QNTM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNTM
Website n/a
1 month ago
+18.6%
Quantum Biopharma shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
+3.41%
Quantum Biopharma shares are trading higher after the company announced it completed its trial titled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants."
